Lymphatic endothelium: Difference between revisions
Content deleted Content added
Citation bot (talk | contribs) m Citation maintenance. Formatted: pages. You can use this bot yourself! Please report any bugs. |
m clean up- spelling of "et al." using AWB |
||
| Line 2: | Line 2: | ||
The '''lymphatic endothelium''' is a specialised form of epithelium, distinct from but similar to [[vascular endothelium]]. |
The '''lymphatic endothelium''' is a specialised form of epithelium, distinct from but similar to [[vascular endothelium]]. |
||
Although lymphatics were first described by [[Hippocrates]] in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 1600s by [[Gasparo Aselli]], they were ignored for centuries until in 1937 [[Howard Florey]] showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that [[VEGF-R3]] and [[VEGF-C]]/[[VEGF-D]] were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being [[LYVE-1]] (Jackson et al,1999)<ref name="J.Cell Biol">{{cite web | title = J.Cell Biol: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan 1| url = http://www.jcb.org/cgi/content/full/144/4/789?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=lyve-1&searchid=1&FIRSTINDEX=0&volume=144&issue=4&resourcetype=HWCIT| accessdate = }}</ref> and podoplanin (Kerjaschki,199)<ref name="American Journal of Pathology">{{cite web | title = Am. J. Pathol: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic andothelium 2| url = http://ajp.amjpathol.org/cgi/content/full/154/2/385?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&titleabstract=Angiosarcomas+express+mixed+endothelial+phenotypes+of+blood+and+lymphatic+capill&searchid=1&FIRSTINDEX=0&firstpage=385&fdate=1/1/1999&tdate=12/31/1999&resourcetype=HWCIT| accessdate = }}</ref> |
Although lymphatics were first described by [[Hippocrates]] in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 1600s by [[Gasparo Aselli]], they were ignored for centuries until in 1937 [[Howard Florey]] showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that [[VEGF-R3]] and [[VEGF-C]]/[[VEGF-D]] were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being [[LYVE-1]] (Jackson et al.,1999)<ref name="J.Cell Biol">{{cite web | title = J.Cell Biol: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan 1| url = http://www.jcb.org/cgi/content/full/144/4/789?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=lyve-1&searchid=1&FIRSTINDEX=0&volume=144&issue=4&resourcetype=HWCIT| accessdate = }}</ref> and podoplanin (Kerjaschki,199)<ref name="American Journal of Pathology">{{cite web | title = Am. J. Pathol: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic andothelium 2| url = http://ajp.amjpathol.org/cgi/content/full/154/2/385?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&titleabstract=Angiosarcomas+express+mixed+endothelial+phenotypes+of+blood+and+lymphatic+capill&searchid=1&FIRSTINDEX=0&firstpage=385&fdate=1/1/1999&tdate=12/31/1999&resourcetype=HWCIT| accessdate = }}</ref> |
||
==References== |
==References== |
||
| Line 27: | Line 27: | ||
}} |
}} |
||
{{refend}} |
{{refend}} |
||
{{science-stub}} |
{{science-stub}} |
||
Revision as of 01:18, 15 May 2009
The lymphatic endothelium is a specialised form of epithelium, distinct from but similar to vascular endothelium.
Although lymphatics were first described by Hippocrates in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 1600s by Gasparo Aselli, they were ignored for centuries until in 1937 Howard Florey showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that VEGF-R3 and VEGF-C/VEGF-D were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being LYVE-1 (Jackson et al.,1999)[1] and podoplanin (Kerjaschki,199)[2]
References
Further reading
 | This science article is a stub. You can help Wikipedia by expanding it. |